Effectiveness of a new multi-component smoking cessation service package for patients with hypertension and diabetes in northern Thailand: a randomized controlled trial (ESCAPE study)

Substance Abuse Treatment, Prevention, and Policy - Tập 14 - Trang 1-10 - 2019
Myo Nyein Aung1,2, Motoyuki Yuasa3, Saiyud Moolphate4, Thaworn Lorga5, Hirohide Yokokawa6, Hiroshi Fukuda6, Tsutomu Kitajima7, Susumu Tanimura8, Yoshimune Hiratsuka9, Koichi Ono9, Payom Thinuan5, Kazuo Minematsu10, Jitladda Deerojanawong2, Yaoyanee Suya11, Eiji Marui12
1Advanced Health Science Institute, and Faculty of International Liberal Arts, Juntendo University, Tokyo, Japan
2WHO Collaborating Center for Medical Education, Faculty of Medicine, Chulalogkorn University, Bangkok, Thailand
3Faculty of International Liberal Arts and Department of Public Health, School of Medicine, Juntendo University , Tokyo, Japan
4Department of Public Health, Faculty of Science and Technology, Chiang Mai Rajabhat University, Chiang Mai, Thailand
5Boromrajonani College of Nursing, Lampang, Thailand
6Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan
7Faculty of Social Science, Kyorin University, Tokyo, Japan
8Department of Public Health Nursing, Mie University Graduate School of Medicine, Tsu, Japan
9Department of Opthalmology, Juntendo University School of Medicine, Tokyo, Japan
10Graduate School of Education, Nagasaki University, Nagasaki, Japan
11Maetha Hospital, Lampang, Thailand
12Department of Human Arts and Sciences, University of Human Arts and Sciences, Saitama, Japan

Tóm tắt

Smoking cessation is an achievable behavioral change, which reduces the risks of cardiovascular diseases, cancers and tobacco-related diseases. There is a need for an effective smoking cessation service for low and middle income country settings where the smoking rate is generally very high whilst a cessation service is not usually accessible. This study devised a new smoking cessation service package and assessed its effectiveness in the primary health care setting of northern Thailand. This randomized controlled trial was centered at Maetha district hospital, Lampang province, Thailand, and its network of mobile non-communicable disease clinics at seven primary care units. A total of 319 eligible patients who consented to participate in the study, were randomly allocated to an intervention arm (160) and a control arm (159), applying block randomization. The multi-component intervention service consisted of: The control group received the routine service comprising of brief counseling and casual follow-up. Smoking cessation, confirmed by six months of abstinence and the piCo+ Smokerlyzer breath test, was compared between the two services after a year follow-up. The trial is registered as an international current control trial at the ISRCTN registry. ISRCTN89315117. The median age of the participants was 64 years, with females constituting 28.84%. Most of the participants smoke hand-rolled cigarettes (85%). The intervention arm participants achieved a significantly higher smoking cessation rate than the control arm 25.62% vs 11.32%, with an adjusted odd ratio of 2.95 and 95% confidence interval 1.55–5.61. In relation to accessing smoking cessation services within the primary health care setting, participants who received the evidence-based intervention package were about three times more likely to succeed in giving up smoking than those who received the routine service. Utilizing community resources as major intervention components, the evidence from this trial may provide a useful and scalable smoking cessation intervention for low and middle income countries. Current controlled trials ISRCTN89315117 . WHO international clinical trial identifier number: U1111–1145-6916; 3/2013.

Tài liệu tham khảo

Aung MN, Yuasa M, Moolphate S, et al. Challenges for smoking cessation intervention as part of primary health Care Services in Developing Countries. J Smok Cessat. 2014;11(4):211–8. Piné-Abata H, McNeill A, Murray R, Bitton A, Rigotti N, Raw M. A survey of tobacco dependence treatment services in 121 countries. Addiction. 2013;108(8):1476–84. Picazo OF. Engendering Concerted National Efforts towards Improved Health Outcomes in the ASEAN: Status, Challenges, Targets, and Ways Forward; 2015. Ward KD, Asfar T, Al Ali R, et al. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction. 2013;108(2):394–403. Lai DT, Cahill K, Qin Y, Tang JL. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2010;1:CD006936. Hong-Qiang S, Song G, Da-Fang C, et al. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in Chinese smokers. Am J Drug Alcohol Abuse. 2009;35(3):183–8. Park EW, Tudiver FG, Campbell T. Enhancing partner support to improve smoking cessation. Cochrane Database Syst Rev. 2012;7:CD002928. Luker KA, Chalmers KI, Caress AL, Salmon MP. Smoking cessation interventions in chronic obstructive pulmonary disease and the role of the family: a systematic literature review. J Adv Nurs. 2007;59(6):559–68. Aung MN, Yuasa M, Lorga T, et al. Evidence-based new service package vs. routine service package for smoking cessation to prevent high risk patients from cardiovascular diseases (CVD): study protocol for randomized controlled trial. Trials. 2013;14:419. ISRCTN89315117: Effective Smoking Cessation Augmented PackagE (ESCAPE): evidence-based new service package vs. routine package to stop smoking. 2013; http://controlled-trials.com/ISRCTN89315117. Accessed 20 Jul 2013. Ríos-Bedoya CF, Snedecor SM, Pomerleau CS, Pomerleau OF. Association of withdrawal features with nicotine dependence as measured by the Fagerström test for nicotine dependence (FTND). Addict Behav. 2008;33(8):1086–9. Fagerstrom KO, Heatherton TF, Kozlowski L. Nicotine addiction and its assessment. Ear Nose Throat J. 1990;69(11):763–5. Borland R, Li L, Driezen P, et al. Cessation assistance reported by smokers in 15 countries participating in the international tobacco control (ITC) policy evaluation surveys. Addiction. 2012;107(1):197–205. Pumsawad V. Clinical practice guideline in smoking cessation Thailand ministry of public health; 2003. Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug and alcohol dependence. 2013;128(1-2):15–19. Young D, Yong H-H, Borland R, et al. Prevalence and correlates of roll-your-own smoking in Thailand and Malaysia: findings of the ITC-South East Asia survey. Nicotine Tob Res. 2008;10(5):907–15. World Health Organization: Global Helath Observatory: Health system response and capacity to address and respond to NCDs. 2013; http://www.who.int/gho/ncd/health_system_response/en/. Accessed 19 Dec 2013. Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, Abbafati C, Abera SF, Abraham B, Abyu GY, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet 2017;389(10082):1885–906. Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews. Addiction. 2013;108(10):1711–21. McLeroy KR, Norton BL, Kegler MC, Burdine JN, Sumaya CV. Community-based interventions. Am J Public Health. 2003;93(4):529–33. Siddiqi K, Khan A, Ahmad M, et al. Action to stop smoking in suspected tuberculosis (ASSIST) in PakistanA cluster randomized, controlled trial. Ann Intern Med. 2013;158(9):667–75. Thankappan K, Mini G, Daivadanam M, Vijayakumar G, Sarma P, Nichter M. Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India. BMC Public Health. 2013;13(1):47. Little RJ, D'Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355–60. Meeyai A, Yunibhand J, Punkrajang P, Pitayarangsarit S. An evaluation of usage patterns, effectiveness and cost of the national smoking cessation quitline in Thailand. Tob Control. 2015;24(5):481–8. Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y. Tobacco smoking. In: Respiratory health and disease in Europe: the new European Lung White Book. 1st edn. Eur Respiratory Soc. 2013;98–111. https://www.erswhitebook.org/files/public/Chapters/09_tobacco_smoking.pdf. Sangthong R, Wichaidit W, Ketchoo C. Current situation and future challenges of tobacco control policy in Thailand. Tob Control. 2012;21(1):49–54. Goodchild M, Nargis N, Tursan d'Espaignet E. Global economic cost of smoking-attributable diseases. Tobacco control. 2018;27(1):58–64.
Thông tin
Thông tin xuất bản

Substance Abuse Treatment, Prevention, and Policy

Tập 14

1-10

Thông tin tác giả